NCIt definition : An agonistic antibody that recognizes the co-stimulatory receptor OX40 (CD134; TNFRSF4),
with potential immunostimulatory activity. Upon administration, ivuxolimab selectively
binds to and activates OX40; which induces proliferation of memory and effector T-lymphocytes.
In the presence of tumor-associated antigens (TAAs), this may promote a T-cell-mediated
immune response against TAA-expressing tumor cells. OX40, a cell surface glycoprotein
and member of the tumor necrosis factor receptor superfamily (TNFRSF), is expressed
on T-lymphocytes and plays an essential role in T-cell activation.;
UNII : APS3IS9D6W;
CAS number : 2128729-41-7; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 2128729-41-7
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;